Ensayo clínico de una droga: La Nitroimidazina (1-N-Etilmorfolin-5-Nitroimidazol) en la tricomoniasis genital
This clinical trial evaluated the efficacy of Nitroimidazina, specifically 1-N-Ethylmorpholin-5-Nitroimidazole, in treating genital trichomoniasis among women of reproductive age. The study was conducted at the University Hospital del Valle in Cali, Colombia, where vaginal trichomoniasis demonstrated a prevalence of 13% in the examined outpatient population. The paper focuses exclusively on the therapeutic outcomes for this sexually transmitted infection and does not address other gynecological pathologies. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,462 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (3)
- W1532734430 via openalex
- W2094049144 via openalex
- W2200320694 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00